1. Home
  2. GOGO vs EDIT Comparison

GOGO vs EDIT Comparison

Compare GOGO & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogo Inc.

GOGO

Gogo Inc.

HOLD

Current Price

$3.35

Market Cap

461.2M

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.76

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOGO
EDIT
Founded
1991
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
461.2M
432.8M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
GOGO
EDIT
Price
$3.35
$2.76
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$15.00
$5.30
AVG Volume (30 Days)
2.4M
3.7M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.50
EPS
0.10
N/A
Revenue
$910,491,000.00
$31,937,000.00
Revenue This Year
$3.68
N/A
Revenue Next Year
$3.60
N/A
P/E Ratio
$33.10
N/A
Revenue Growth
104.74
132.64
52 Week Low
$3.23
$1.66
52 Week High
$16.82
$4.54

Technical Indicators

Market Signals
Indicator
GOGO
EDIT
Relative Strength Index (RSI) 35.26 50.25
Support Level $3.29 $2.47
Resistance Level $4.92 $3.27
Average True Range (ATR) 0.27 0.22
MACD -0.04 0.01
Stochastic Oscillator 10.81 52.56

Price Performance

Historical Comparison
GOGO
EDIT

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped. Geographically, it operates in United States; and International as well.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: